Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030

icon1
USD 50.69
MARKET SIZE,
icon2
CAGR 11.2%
(-)
icon3
762
REPORT PAGES
icon4
1000
MARKET TABLES

OVERVIEW

cell-culture-market-media-sera-reagents Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The cell culture market is projected to reach USD 50.69 billion by 2030 from USD 29.76 billion in 2025, at a CAGR of 11.2% from 2025 to 2030. The growth of the cell culture market is driven by the increasing support and funding from government and private organizations for cell-based research and growing popularity of monoclonal antibodies & biosimilars.

KEY TAKEAWAYS

  • BY REGION
    In 2024, North America is expected to hold the largest market share of 39.8%, supported by the rising approvals of cell-culture-
  • BY PRODUCT
    In 2024, the consumables segment accounted for 73.6% of the cell culture market, driven by the repeated purchase of consumable and rising research for funding.
  • BY APPLICATION
    The biopharmaceutical production segment is expected to grow at the highest CAGR of 12.3% during the forecast period.
  • BY END USER
    In 2024, pharmaceutical and biotechnology companies accounted for the largest share of the cell culture market, due to their extensive use of cell culture systems in biologics manufacturing.
  • COMPETITIVE LANDSCAPE
    Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Sartorius AG, and Corning Incorporated are dominant companies in this market.

The cell culture market is witnessing steady growth, driven by increasing funding and support for cell-based research and the emergence of advanced cell culture technologies. Rising adoption of single-use systems and the growing popularity of monoclonal antibodies, biosimilars, and advanced therapy medicinal products are driving demand. Additionally, frequent product launches and the increasing incidence of infectious diseases are further boosting market expansion.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Key trends and disruptions shaping the cell culture market include the rising adoption of 3D cell culture and organ-on-chip technologies, which enable more physiologically relevant models and accelerate drug discovery. The increasing shift toward serum-free and chemically defined media is enhancing reproducibility and reducing the risk of contamination. Additionally, the growing demand for biopharmaceuticals and personalized medicine is driving the need for higher throughput and automation in cell culture workflows, while sustainability pressures are prompting the development of eco-friendly consumables and processes.

cell-culture-market-media-sera-reagents Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing support and funding for cell-based research
  • Emerging cell culture technologies
RESTRAINTS
Impact
Level
  • High cost of cell biology research
  • Limitations in producing high density cell cultures
OPPORTUNITIES
Impact
Level
  • Rising demand for 3D cell culture
  • Increasing focus on next-generation therapeutics
CHALLENGES
Impact
Level
  • Disposal of plastic consumables
  • Ethical concerns related to cell usage

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing support and funding for cell-based research

Cell culture is used to develop biological products for treating various diseases, such as cancer and cardiovascular conditions. Globally, major research and development activities are underway to create new and innovative cell therapy products, funded by both government and private organizations. For example, in June 2025, Celltrio (US), a life sciences company, secured USD 15 million in funding led by Premier Partners to accelerate the global commercialization of RoboCell, its flagship automated platform for sterile cell culturing and cell therapy manufacturing. Additionally, in May 2025, the Maryland Stem Cell Research Commission (US) announced grants exceeding USD 18 million to support cutting-edge stem cell and regenerative medicine research across Maryland.

Restraint:High cost of cell biology research

Cell biology research is an expensive process, requiring advanced laboratory equipment, specialized reagents, and skilled personnel. These high costs directly impact the adoption of microcarrier-based technologies for large-scale cell culture and production, as they add to the overall expenditure of R&D projects. Researchers and small-scale pharmaceutical & biotechnology companies may face budget constraints and prioritization of funds, which can limit their capacity to invest in microcarrier-based systems.

Opportunity: Rising demand for 3D Cell Culture

3D cell cultures are becoming more popular than 2D cell cultures for several reasons. 2D cell culture methods involve growing cells on flat surfaces as monolayers. However, these cells only adhere to the surface of the culture vessel and attach mainly at the edges. This restricts their ability to simulate a true 3D environment. Researchers have developed 3D cell cultures to address these limitations. These cultures have been shown to be effective in various studies of basic biological processes, such as monitoring cell number, assessing cell viability, observing cell proliferation, and examining cell structure. Additionally, 3D cell cultures offer greater stability and longer lifespans compared to 2D cultures.

Challenge: Disposal of plastic consumables

Cell culture is a flexible research method. However, it depends heavily on plastic consumables, which generate large amounts of plastic waste annually, negatively impacting the environment. Additionally, biopharmaceutical companies are increasingly using single-use bioprocessing systems and consumables because of their benefits, such as lower costs, faster process development, and reduced capital investment. They also help cut utility and water expenses during cleaning, sterilization, and batch changeover. Nevertheless, the disposal of solid waste from this technology raises serious environmental concerns.

CELL CULTURE MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Collaborated with Universitat Autònoma de Barcelona to optimize cell culture media for CHO-S cells, enhancing protein productivity Achieved a 1.7-fold increase in monoclonal antibody productivity, demonstrating the impact of media optimization on cell culture efficiency
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production Demonstrated that XDR bioreactors can be used effectively for antibody production | The System met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | Real-time CO2 monitoring proved effective, allowing the maintenance of optimal culture conditions
Growing NS0 cells in disposable bioreactors for clinical trial production Process scale-up in single-use systems was confirmed at 50 L and 250 L scale | GMP manufacturing was conducted at 2,000 L scale in single-use bioreactors | The 1st biological drug manufactured in China for global clinical trials was successfully produced by WuXi Biologics’ manufacturing site in Wuxi city

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The cell culture market ecosystem comprises raw material suppliers, cell culture product manufacturers, and end users such as pharmaceutical and biotechnology companies, research & academic institutes, hospitals & diagnostic laboratories, CROs, and cell banks. Cell culture product manufacturers provide consumables, including media, reagents, sera, vessels, and accessories, as well as equipment such as bioreactors, storage equipment, and other equipment.

cell-culture-market-media-sera-reagents Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

cell-culture-market-media-sera-reagents Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Cell Culture Market, By Product

As of 2024, the consumables segment dominates the cell culture market as these products are essential for routine operations and are required in large volumes for every experimental or production cycle. Continuous advancements in media formulations and reagents have improved cell yield and consistency, increasing dependence on high-quality consumables. Furthermore, the growing shift toward single-use culture systems has amplified recurring demand, making consumables a key revenue driver in the market.

Cell Culture Market, By Application

The biopharmaceutical production segment accounts for the largest share of the market owing to the expanding global demand for biologics and the increased adoption of mammalian cell culture systems in large-scale drug manufacturing. Enhanced focus on process optimization, scalability, and regulatory compliance has further accelerated the use of cell culture in production workflows. Additionally, rising investments in capacity expansion and contract manufacturing for biologics strengthen this segment’s leadership.

Cell Culture Market, By End User

In 2024, pharmaceutical & biotechnology companies held the largest market share in the global cell culture market, owing to growing demand for biopharmaceuticals and personalized medicine, advancements in cell-based therapies and regenerative medicine, and the need for scalable and cost-effective production methods.

REGION

Asia Pacific to be fastest-growing region in global cell culture market during forecast period

The Asia Pacific cell culture market is expected to register the highest CAGR during the forecast period, driven by increasing investments in biopharmaceutical R&D and expanding manufacturing capabilities across countries like China, India, South Korea, and Japan. Growing government support for the development of advanced therapies and rising demand for vaccines and biosimilars are further propelling regional growth. Additionally, the presence of cost-effective production infrastructure and the expansion of multinational biopharma companies in the region are enhancing market potential.

cell-culture-market-media-sera-reagents Region

CELL CULTURE MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMPANY EVALUATION MATRIX

In the cell culture market matrix, Thermo Fisher Scientific Inc. (Star) leads with a strong market share, extensive product footprint, and broad application coverage across biopharmaceutical, research, and clinical segments. Its comprehensive presence across consumables, instruments reinforces its leadership position. FUJIFILM Holdings Corporation (Emerging Leader) is rapidly expanding cell culture capabilities supported by both organic R&D initiatives, product launched and strategic acquisitions. The company’s growing global footprint and strengthening market rank indicate its increasing influence and potential to transition into a leading position in the coming years.

cell-culture-market-media-sera-reagents Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 27.92 Billion
Market Forecast in 2030 (Value) USD 50.69 Billion
Growth Rate CAGR of 11.2% from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product:
    • Consumables
    • Equipment
  • By Application:
    • Biopharmaceutical Production
    • Diagnostics
    • Tissue Engineering & Regenerative Medicine
    • Drug Screening & Development
    • Other Applications
  • By End User:
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Diagnostic Laboratories
    • Research & Academic Institutes
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa

WHAT IS IN IT FOR YOU: CELL CULTURE MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS REPORT CONTENT GUIDE

cell-culture-market-media-sera-reagents Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Global Cell Culture Consumables Market
  • Market size estimation for the cell culture consumables market based on product type and application at global level
  • Strategic analysis of product type, application segments based on scale of operations (R&D and commerical scale)
  • Targeted Market Understanding
  • Highlights niche opportunities in specialized media and reagents
  • Supports data-driven decisions for capacity and market expansion
Global 3D Cell Culture Vessels Market Opportunity Assessment and Competitive Analysis
  • Market size estimation and forecast for the 3D cell culture vessels market based on product type, application, and customer type at the global and regional level
  • Detailed information regarding the major factors (such as drivers, restraints, opportunities, challenges) influencing the market growth
  • Analysis of key players in the market and their product benchmarking
  • Delivers insights into key market drivers and competitive positioning
  • Provides forecasts to identify regional and application-based growth
  • Aids investment focus through benchmarking and opportunity mapping

RECENT DEVELOPMENTS

  • May 2025 : BD launched a cell analyzer BD FACSDiscover A8 Cell Analyzer featuring spectral and real-time cell imaging technologies.
  • April 2025 : Sartorius acquired MatTek, a leading developer and manufacturer of 3D microtissue models, from BICO Group AB (Sweden). This acquisition will advance Sartorius’ cell culture portfolio.
  • April 2025 : Thermo Fisher Scientific Inc. opened the Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, Calif. This advanced facility is designed to accelerate the development and commercialization of cell therapies.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
59
2
RESEARCH METHODOLOGY
 
 
 
 
 
64
3
EXECUTIVE SUMMARY
 
 
 
 
 
77
4
PREMIUM INSIGHTS
 
 
 
 
 
80
5
MARKET OVERVIEW
Cell biology market thrives on innovation, funding boosts, and surging demand for advanced therapeutics.
 
 
 
 
 
83
 
5.1
INTRODUCTION
 
 
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
 
 
5.2.1.1
INCREASING SUPPORT AND FUNDING FOR CELL-BASED RESEARCH
 
 
 
 
 
 
5.2.1.2
EMERGING CELL CULTURE TECHNOLOGIES
 
 
 
 
 
 
5.2.1.3
GROWING POPULARITY OF MONOCLONAL ANTIBODIES AND BIOSIMILARS
 
 
 
 
 
 
5.2.1.4
INCREASING ADOPTION OF SINGLE-USE TECHNOLOGIES
 
 
 
 
 
 
5.2.1.5
RISE IN PRODUCT LAUNCHES
 
 
 
 
 
 
5.2.1.6
GROWTH IN ADVANCED THERAPY MEDICINAL PRODUCTS
 
 
 
 
 
 
5.2.1.7
INCREASING INCIDENCE OF INFECTIOUS DISEASES
 
 
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
 
 
5.2.2.1
HIGH COST OF CELL BIOLOGY RESEARCH
 
 
 
 
 
 
5.2.2.2
LIMITATIONS IN PRODUCING HIGH-DENSITY CELL CULTURES
 
 
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
5.2.3.1
RISING DEMAND FOR 3D CELL CULTURE
 
 
 
 
 
 
5.2.3.2
GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
 
 
 
 
 
 
5.2.3.3
INCREASING FOCUS ON NEXT-GENERATION THERAPEUTICS
 
 
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
 
 
5.2.4.1
DISPOSAL OF PLASTIC CONSUMABLES
 
 
 
 
 
 
5.2.4.2
ETHICAL CONCERNS RELATED TO CELL USAGE
 
 
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.4
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.4.1
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
 
 
 
 
 
 
5.4.2
AVERAGE SELLING PRICE OF PRODUCTS, BY REGION
 
 
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.6
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.7
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
 
5.8
TECHNOLOGY ANALYSIS
 
 
 
 
 
 
 
5.8.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
5.8.1.1
SINGLE-USE TECHNOLOGY
 
 
 
 
 
 
5.8.1.2
FLOW CYTOMETRY
 
 
 
 
 
 
5.8.1.3
MICROSCOPY
 
 
 
 
 
5.8.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
5.8.2.1
HIGH-THROUGHPUT SCREENING
 
 
 
 
 
 
5.8.2.2
MASS SPECTROMETRY
 
 
 
 
 
5.8.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
5.8.3.1
MICROFLUIDICS AND ORGAN-ON-A-CHIP
 
 
 
 
 
 
5.8.3.2
3D BIOPRINTING
 
 
 
 
5.9
PATENT ANALYSIS
 
 
 
 
 
 
 
5.10
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.10.1
IMPORT DATA
 
 
 
 
 
 
5.10.2
EXPORT DATA
 
 
 
 
 
5.11
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
 
 
5.12
TARIFF AND REGULATORY LANDSCAPE
 
 
 
 
 
 
 
 
5.12.1
TARIFF RELATED TO CELL CULTURE PRODUCTS
 
 
 
 
 
 
5.12.2
REGULATORY FRAMEWORK
 
 
 
 
 
 
 
5.12.2.1
NORTH AMERICA
 
 
 
 
 
 
5.12.2.2
EUROPE
 
 
 
 
 
 
5.12.2.3
ASIA PACIFIC
 
 
 
 
 
 
5.12.2.4
LATIN AMERICA
 
 
 
 
 
 
5.12.2.5
MIDDLE EAST & AFRICA
 
 
 
 
 
5.12.3
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
5.13
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.13.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.13.2
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.13.3
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.13.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.13.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.14
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
 
 
5.14.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
5.14.2
KEY BUYING CRITERIA
 
 
 
 
 
5.15
IMPACT OF AI/GENERATIVE AI ON CELL CULTURE PRODUCTS MARKET
 
 
 
 
 
 
 
 
5.15.1
INTRODUCTION
 
 
 
 
 
 
5.15.2
MARKET POTENTIAL OF AI IN CELL CULTURE APPLICATIONS
 
 
 
 
 
 
5.15.3
AI USE CASES
 
 
 
 
 
 
5.15.4
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
 
 
5.15.5
FUTURE OF GENERATIVE AI IN CELL CULTURE ECOSYSTEM
 
 
 
 
 
5.16
IMPACT OF 2025 US TARIFF ON CELL CULTURE MARKET
 
 
 
 
 
 
 
 
5.16.1
INTRODUCTION
 
 
 
 
 
 
5.16.2
KEY TARIFF RATES
 
 
 
 
 
 
5.16.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.16.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.16.4.1
US
 
 
 
 
 
 
5.16.4.2
EUROPE
 
 
 
 
 
 
5.16.4.3
ASIA PACIFIC
 
 
 
 
 
5.16.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
 
 
5.16.5.1
PHARMACEUTICAL & BIOTECH COMPANIES
 
 
 
 
 
 
5.16.5.2
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
5.16.5.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
 
5.16.5.4
CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
 
 
 
6
CELL CULTURE MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Liters | 354 Data Tables
 
 
 
 
 
143
 
6.1
INTRODUCTION
 
 
 
 
 
 
6.2
CONSUMABLES
 
 
 
 
 
 
 
6.2.1
SERA, MEDIA, AND REAGENTS
 
 
 
 
 
 
 
6.2.1.1
MEDIA
 
 
 
 
 
 
 
 
6.2.1.1.1
SERUM-FREE MEDIA
 
 
 
 
 
 
6.2.1.1.2
CLASSICAL MEDIA & SALTS
 
 
 
 
 
 
6.2.1.1.3
STEM CELL CULTURE MEDIA
 
 
 
 
 
 
6.2.1.1.4
CHEMICALLY-DEFINED MEDIA
 
 
 
 
 
 
6.2.1.1.5
SPECIALTY MEDIA
 
 
 
 
 
 
6.2.1.1.6
OTHER MEDIA
 
 
 
 
6.2.1.2
REAGENTS
 
 
 
 
 
 
 
 
6.2.1.2.1
GROWTH FACTORS
 
 
 
 
 
 
6.2.1.2.2
SUPPLEMENTS
 
 
 
 
 
 
6.2.1.2.3
BUFFERS & CHEMICALS
 
 
 
 
 
 
6.2.1.2.4
CELL DISSOCIATION REAGENTS
 
 
 
 
 
 
6.2.1.2.5
BALANCED SALT SOLUTIONS
 
 
 
 
 
 
6.2.1.2.6
ATTACHMENT & MATRIX FACTORS
 
 
 
 
 
 
6.2.1.2.7
ANTIBIOTICS/ANTIMYCOTICS
 
 
 
 
 
 
6.2.1.2.8
CRYOPROTECTIVE REAGENTS
 
 
 
 
 
 
6.2.1.2.9
CONTAMINATION DETECTION KITS
 
 
 
 
 
 
6.2.1.2.10
OTHER REAGENTS
 
 
 
 
6.2.1.3
SERA
 
 
 
 
 
 
 
 
6.2.1.3.1
FETAL BOVINE SERA
 
 
 
 
 
 
6.2.1.3.2
ADULT BOVINE SERA
 
 
 
 
 
 
6.2.1.3.3
OTHER ANIMAL SERA
 
 
 
6.2.2
VESSELS
 
 
 
 
 
 
 
6.2.2.1
CELL FACTORY SYSTEMS/CELL STACKS
 
 
 
 
 
 
 
 
6.2.2.1.1
EFFICIENT AND SCALABLE SOLUTIONS FOR LARGE-SCALE EXPANSION TO DRIVE ADOPTION
 
 
 
 
6.2.2.2
ROLLER/ROUX BOTTLES
 
 
 
 
 
 
 
 
6.2.2.2.1
SCALABILITY, COST-EFFECTIVENESS, AND EASE OF HANDLING TO SUPPORT GROWTH
 
 
 
 
6.2.2.3
FLASKS
 
 
 
 
 
 
 
 
6.2.2.3.1
GROWING ADVANCEMENTS IN CELL CULTURE FLASKS TO BOOST MARKET
 
 
 
 
6.2.2.4
MULTIWELL PLATES
 
 
 
 
 
 
 
 
6.2.2.4.1
INCREASING ADOPTION OF MULTIWELL PLATES IN HIGH-THROUGHPUT OR HIGH-CONTENT SCREENING TO AID GROWTH
 
 
 
 
6.2.2.5
PETRI DISHES
 
 
 
 
 
 
 
 
6.2.2.5.1
RISING USE OF PETRI DISHES AS STERILE CONTAINERS TO SUSTAIN GROWTH
 
 
 
6.2.3
ACCESSORIES
 
 
 
 
 
 
 
6.2.3.1
REDUCED PREPARATION TIME AND EQUIPMENT PERFORMANCE IMPROVEMENTS TO AUGMENT GROWTH
 
 
 
 
6.3
EQUIPMENT
 
 
 
 
 
 
 
6.3.1
BIOREACTORS
 
 
 
 
 
 
 
6.3.1.1
CONVENTIONAL BIOREACTORS
 
 
 
 
 
 
 
 
6.3.1.1.1
UTILIZATION IN LARGE-SCALE MANUFACTURING OF DRUGS TO DRIVE MARKET
 
 
 
 
6.3.1.2
SINGLE-USE BIOREACTORS
 
 
 
 
 
 
 
 
6.3.1.2.1
LOWER OPERATIONAL COSTS AND INCREASED FLEXIBILITY TO BOOST MARKET
 
 
 
6.3.2
STORAGE EQUIPMENT
 
 
 
 
 
 
 
6.3.2.1
REFRIGERATORS & FREEZERS
 
 
 
 
 
 
 
 
6.3.2.1.1
INCREASING NEED FOR STORAGE SOLUTIONS TO PROPEL MARKET
 
 
 
 
6.3.2.2
CRYOSTORAGE SYSTEMS
 
 
 
 
 
 
 
 
6.3.2.2.1
BENEFITS OF LONG-TERM PRESERVATION OF CELL CULTURES TO SUPPORT GROWTH
 
 
 
6.3.3
OTHER EQUIPMENT
 
 
 
 
 
 
 
6.3.3.1
FILTRATION SYSTEMS
 
 
 
 
 
 
 
 
6.3.3.1.1
GROWING USE IN BIOPROCESSING INDUSTRY TO BOOST MARKET
 
 
 
 
6.3.3.2
CELL COUNTERS
 
 
 
 
 
 
 
 
6.3.3.2.1
GROWING ADOPTION OF AUTOMATED CELL COUNTERS TO PROPEL MARKET
 
 
 
 
6.3.3.3
CARBON DIOXIDE INCUBATORS
 
 
 
 
 
 
 
 
6.3.3.3.1
INCREASING FOCUS OF RESEARCH INSTITUTES ON DEVELOPING LAB-SCALE INCUBATORS TO DRIVE MARKET
 
 
 
 
6.3.3.4
CENTRIFUGES
 
 
 
 
 
 
 
 
6.3.3.4.1
INCREASING DEMAND FOR BIOPRODUCTION APPLICATIONS TO DRIVE ADOPTION OF CENTRIFUGES
 
 
 
 
6.3.3.5
AUTOCLAVES
 
 
 
 
 
 
 
 
6.3.3.5.1
RELIANCE ON SINGLE-USE LABWARE AND EQUIPMENT TO AFFECT DEMAND FOR AUTOCLAVES
 
 
 
 
6.3.3.6
MICROSCOPES
 
 
 
 
 
 
 
 
6.3.3.6.1
ENHANCED IMAGING CAPABILITIES TO AUGMENT GROWTH
 
 
 
 
6.3.3.7
BIOSAFETY CABINETS
 
 
 
 
 
 
 
 
6.3.3.7.1
INCREASING LAUNCHES OF BIOSAFETY CABINETS TO PROMOTE GROWTH
 
 
 
 
6.3.3.8
OTHER SUPPORTING EQUIPMENT
 
 
 
7
CELL CULTURE MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 73 Data Tables
 
 
 
 
 
319
 
7.1
INTRODUCTION
 
 
 
 
 
 
7.2
BIOPHARMACEUTICAL PRODUCTION
 
 
 
 
 
 
 
7.2.1
MONOCLONAL ANTIBODY PRODUCTION
 
 
 
 
 
 
 
7.2.1.1
INCREASING APPROVAL AND LAUNCH OF MAB CANDIDATES TO AMPLIFY GROWTH
 
 
 
 
 
7.2.2
VACCINE PRODUCTION
 
 
 
 
 
 
 
7.2.2.1
RISING INCIDENCE OF INFECTIOUS DISEASES TO SUPPORT GROWTH
 
 
 
 
 
7.2.3
OTHER THERAPEUTIC PROTEIN PRODUCTION
 
 
 
 
 
7.3
DIAGNOSTICS
 
 
 
 
 
 
 
7.3.1
GROWING ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO FUEL MARKET
 
 
 
 
 
7.4
TISSUE ENGINEERING & REGENERATIVE MEDICINE
 
 
 
 
 
 
 
7.4.1
CELL & GENE THERAPY
 
 
 
 
 
 
 
7.4.1.1
RISING INVESTMENTS IN DEVELOPING CELL-BASED IMMUNOTHERAPIES TO FOSTER GROWTH
 
 
 
 
 
7.4.2
OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
 
 
 
 
 
7.5
DRUG SCREENING & DEVELOPMENT
 
 
 
 
 
 
 
7.5.1
INCREASING FOCUS ON BIOLOGIC DRUGS TO FAVOR GROWTH
 
 
 
 
 
7.6
OTHER APPLICATIONS
 
 
 
 
 
8
CELL CULTURE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 30 Data Tables
 
 
 
 
 
359
 
8.1
INTRODUCTION
 
 
 
 
 
 
8.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
8.2.1
INCREASING DEMAND FOR CULTURE CELL LINES FOR DRUG SCREENING AND R&D TO AID GROWTH
 
 
 
 
 
8.3
HOSPITALS & DIAGNOSTIC LABORATORIES
 
 
 
 
 
 
 
8.3.1
GROWING USE OF CELL CULTURE FOR CELLULAR PHYSIOLOGY, DISEASE MECHANISMS, AND DRUG RESPONSES TO BOOST MARKET
 
 
 
 
 
8.4
RESEARCH & ACADEMIC INSTITUTES
 
 
 
 
 
 
 
8.4.1
RISING FUNDING ACTIVITIES TO CONTRIBUTE TO GROWTH
 
 
 
 
 
8.5
OTHER END USERS
 
 
 
 
 
9
CELL CULTURE MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 428 Data Tables.
 
 
 
 
 
377
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
NORTH AMERICA
 
 
 
 
 
 
 
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
 
9.2.2
US
 
 
 
 
 
 
 
9.2.2.1
ADVANCED HEALTHCARE INFRASTRUCTURE AND GOVERNMENT SUPPORT TO BOLSTER GROWTH
 
 
 
 
 
9.2.3
CANADA
 
 
 
 
 
 
 
9.2.3.1
INCREASING FUNDING AND INVESTMENTS FOR CELL-BASED THERAPIES TO BOOST MARKET
 
 
 
 
9.3
EUROPE
 
 
 
 
 
 
 
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
 
9.3.2
GERMANY
 
 
 
 
 
 
 
9.3.2.1
RISING R&D INVESTMENTS AND STRATEGIC ALLIANCES TO PROMOTE GROWTH
 
 
 
 
 
9.3.3
UK
 
 
 
 
 
 
 
9.3.3.1
GROWTH IN LIFE SCIENCE INDUSTRY AND FAVORABLE GOVERNMENT INVESTMENTS TO DRIVE MARKET
 
 
 
 
 
9.3.4
FRANCE
 
 
 
 
 
 
 
9.3.4.1
RISING NUMBER OF CELL-BASED RESEARCH PROJECTS TO ENHANCE GROWTH
 
 
 
 
 
9.3.5
ITALY
 
 
 
 
 
 
 
9.3.5.1
STRONG GOVERNMENT SUPPORT FOR R&D ACTIVITIES TO SPUR GROWTH
 
 
 
 
 
9.3.6
SPAIN
 
 
 
 
 
 
 
9.3.6.1
BOOMING BIOTECHNOLOGY INDUSTRY TO BOLSTER GROWTH
 
 
 
 
 
9.3.7
REST OF EUROPE
 
 
 
 
 
9.4
ASIA PACIFIC
 
 
 
 
 
 
 
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
 
9.4.2
CHINA
 
 
 
 
 
 
 
9.4.2.1
RISING FOCUS ON STEM CELL & REGENERATIVE MEDICINE RESEARCH TO EXPEDITE GROWTH
 
 
 
 
 
9.4.3
JAPAN
 
 
 
 
 
 
 
9.4.3.1
RISING GOVERNMENT INITIATIVES AND INCREASING INVESTMENTS IN BIOTECH TO INTENSIFY GROWTH
 
 
 
 
 
9.4.4
INDIA
 
 
 
 
 
 
 
9.4.4.1
FAVORABLE GOVERNMENT SUPPORT AND EXPANSION BY KEY CELL CULTURE PLAYERS TO AUGMENT GROWTH
 
 
 
 
 
9.4.5
SOUTH KOREA
 
 
 
 
 
 
 
9.4.5.1
GROWING PHARMACEUTICAL SECTOR TO DRIVE MARKET
 
 
 
 
 
9.4.6
AUSTRALIA
 
 
 
 
 
 
 
9.4.6.1
INCREASING PREVALENCE OF CHRONIC DISEASES TO ACCELERATE GROWTH
 
 
 
 
 
9.4.7
REST OF ASIA PACIFIC
 
 
 
 
 
9.5
LATIN AMERICA
 
 
 
 
 
 
 
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
 
9.5.2
BRAZIL
 
 
 
 
 
 
 
9.5.2.1
RISING PREVALENCE OF CANCER AND RELATED RESEARCH ACTIVITIES TO SUPPORT GROWTH
 
 
 
 
 
9.5.3
MEXICO
 
 
 
 
 
 
 
9.5.3.1
INCREASING ADVANCEMENTS IN BIOTECHNOLOGY INDUSTRY TO SPUR GROWTH
 
 
 
 
 
9.5.4
REST OF LATIN AMERICA
 
 
 
 
 
9.6
MIDDLE EAST
 
 
 
 
 
 
 
9.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST
 
 
 
 
 
 
9.6.2
GCC COUNTRIES
 
 
 
 
 
 
 
9.6.2.1
SAUDI ARABIA
 
 
 
 
 
 
 
 
9.6.2.1.1
INCREASING FOCUS OF KEY PLAYERS ON EXPANSION TO DRIVE MARKET
 
 
 
 
9.6.2.2
UAE
 
 
 
 
 
 
 
 
9.6.2.2.1
INCREASING SHIFT FROM IMPORTING TO MANUFACTURING PHARMACEUTICALS TO BOOST MARKET
 
 
 
 
9.6.2.3
REST OF GCC COUNTRIES
 
 
 
 
 
9.6.3
REST OF MIDDLE EAST
 
 
 
 
 
9.7
AFRICA
 
 
 
 
 
 
 
9.7.1
RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FOSTER GROWTH
 
 
 
 
 
 
9.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
 
 
10
COMPETITIVE LANDSCAPE
Discover strategic insights and market positions of key players shaping the cell culture industry.
 
 
 
 
 
584
 
10.1
OVERVIEW
 
 
 
 
 
 
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL CULTURE MARKET
 
 
 
 
 
10.3
REVENUE ANALYSIS, 2020–2024
 
 
 
 
 
 
 
10.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
 
 
10.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
 
10.6
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
10.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
 
 
10.7.1
STARS
 
 
 
 
 
 
10.7.2
EMERGING LEADERS
 
 
 
 
 
 
10.7.3
PERVASIVE PLAYERS
 
 
 
 
 
 
10.7.4
PARTICIPANTS
 
 
 
 
 
 
10.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
 
 
10.7.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
10.7.5.2
REGION FOOTPRINT
 
 
 
 
 
 
10.7.5.3
PRODUCT FOOTPRINT
 
 
 
 
 
 
10.7.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
10.7.5.5
END-USER FOOTPRINT
 
 
 
 
10.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
 
10.8.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
10.8.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
10.8.3
DYNAMIC COMPANIES
 
 
 
 
 
 
10.8.4
STARTING BLOCKS
 
 
 
 
 
 
10.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
 
 
10.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
10.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
10.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
10.9.1
PRODUCT LAUNCHES
 
 
 
 
 
 
10.9.2
DEALS
 
 
 
 
 
 
10.9.3
EXPANSIONS
 
 
 
 
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
609
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
KEY PLAYERS
 
 
 
 
 
 
 
11.2.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
 
 
11.2.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
11.2.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
11.2.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
11.2.1.3.1
PRODUCT LAUNCHES
 
 
 
 
 
 
11.2.1.3.2
DEALS
 
 
 
 
 
 
11.2.1.3.3
EXPANSIONS
 
 
 
 
11.2.1.4
MNM VIEW
 
 
 
 
 
 
 
 
11.2.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
11.2.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
11.2.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
 
 
 
11.2.2
DANAHER
 
 
 
 
 
 
11.2.3
MERCK KGAA
 
 
 
 
 
 
11.2.4
SARTORIUS AG
 
 
 
 
 
 
11.2.5
CORNING INCORPORATED
 
 
 
 
 
 
11.2.6
FUJIFILM HOLDINGS CORPORATION
 
 
 
 
 
 
11.2.7
BD
 
 
 
 
 
 
11.2.8
EPPENDORF SE
 
 
 
 
 
 
11.2.9
LONZA
 
 
 
 
 
 
11.2.10
GETINGE
 
 
 
 
 
 
11.2.11
AGILENT TECHNOLOGIES, INC.
 
 
 
 
 
 
11.2.12
HIMEDIA LABORATORIES
 
 
 
 
 
 
11.2.13
BIO-TECHNE
 
 
 
 
 
11.3
OTHER PLAYERS
 
 
 
 
 
 
 
11.3.1
MILTENYI BIOTEC
 
 
 
 
 
 
11.3.2
STEMCELL TECHNOLOGIES
 
 
 
 
 
 
11.3.3
SOLIDA BIOTECH GMBH
 
 
 
 
 
 
11.3.4
CAISSON LABS
 
 
 
 
 
 
11.3.5
PROMOCELL GMBH
 
 
 
 
 
 
11.3.6
INVIVOGEN
 
 
 
 
 
 
11.3.7
PAN-BIOTECH
 
 
 
 
 
 
11.3.8
CELLEXUS
 
 
 
 
 
 
11.3.9
MEISSNER FILTRATION PRODUCTS, INC.
 
 
 
 
 
 
11.3.10
ADOLF KÜHNER AG
 
 
 
 
 
 
11.3.11
ADVANCION CORPORATION
 
 
 
 
 
 
11.3.12
BIOSPHERIX LLC
 
 
 
 
12
APPENDIX
 
 
 
 
 
754
 
12.1
DISCUSSION GUIDE
 
 
 
 
 
 
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
12.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
12.4
RELATED REPORTS
 
 
 
 
 
 
12.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
CELL CULTURE MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
 
 
TABLE 2
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
 
 
TABLE 3
CELL CULTURE MARKET: RISK ANALYSIS
 
 
 
 
 
 
TABLE 4
CELL CULTURE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
 
 
TABLE 5
NATIONAL INSTITUTES OF HEALTH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION)
 
 
 
 
 
 
TABLE 6
FUNDING INVESTMENTS IN CELL & GENE THERAPY, 2023 - 2025
 
 
 
 
 
 
TABLE 7
COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2024
 
 
 
 
 
 
TABLE 8
ASIA PACIFIC: PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023-2025
 
 
 
 
 
 
TABLE 9
COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
 
 
 
 
 
 
TABLE 10
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022–2024
 
 
 
 
 
 
TABLE 11
AVERAGE SELLING PRICE OF SINGLE-USE ASSEMBLIES, BY REGION, 2024
 
 
 
 
 
 
TABLE 12
AVERAGE SELLING PRICE OF MEDIA, BY DEVELOPING VS. DEVELOPED COUNTRIES, 2024
 
 
 
 
 
 
TABLE 13
CELL CULTURE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
 
 
TABLE 14
ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS
 
 
 
 
 
 
TABLE 15
ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
 
 
 
 
 
 
TABLE 16
CELL CULTURE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2025
 
 
 
 
 
 
TABLE 17
IMPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 18
IMPORT DATA FOR HS CODE 382100, 2020–2024 (TONS)
 
 
 
 
 
 
TABLE 19
EXPORT DATA FOR HS CODE 382100, 2020–2024 (USD THOUSAND)
 
 
 
 
 
 
TABLE 20
EXPORT DATA FOR HS CODE 382100, 2020–2024 (TONS)
 
 
 
 
 
 
TABLE 21
CELL CULTURE MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
 
 
TABLE 22
AVERAGE TARIFF RELATED TO CELL CULTURE PRODUCTS FOR HS CODE 382100, 2024
 
 
 
 
 
 
TABLE 23
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 24
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 25
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 26
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 27
CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 28
BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER
 
 
 
 
 
 
TABLE 29
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 30
CELL CULTURE PRODUCTS-RELATED TARIFF REVISION
 
 
 
 
 
 
TABLE 31
IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS
 
 
 
 
 
 
TABLE 32
CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 33
CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 34
CELL CULTURE CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 35
NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 36
EUROPE: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 37
ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 38
LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 39
MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 40
GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 41
CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 42
CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 43
NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 44
EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 45
ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 46
LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 47
MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 48
GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 49
CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 50
CELL CULTURE MEDIA MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 51
CELL CULTURE MEDIA MARKET, BY REGION, 2023–2030 (MILLION LITERS)
 
 
 
 
 
 
TABLE 52
NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 53
EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 54
ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 55
LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 56
MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 57
GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 58
SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 59
CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 60
NORTH AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 61
EUROPE: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 62
ASIA PACIFIC: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 63
LATIN AMERICA: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 64
MIDDLE EAST: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 65
GCC COUNTRIES: CELL CULTURE MARKET FOR SERUM-FREE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 66
CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 67
CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 68
NORTH AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 69
EUROPE: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 70
ASIA PACIFIC: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 71
LATIN AMERICA: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 72
MIDDLE EAST: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 73
GCC COUNTRIES: CELL CULTURE MARKET FOR CLASSICAL MEDIA & SALTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 74
STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 75
CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 76
NORTH AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 77
EUROPE: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 78
ASIA PACIFIC: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 79
LATIN AMERICA: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MIDDLE EAST: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 81
GCC COUNTRIES: CELL CULTURE MARKET FOR STEM CELL CULTURE MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 82
CHEMICALLY-DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 83
CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 84
NORTH AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 85
EUROPE: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 86
ASIA PACIFIC: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 87
LATIN AMERICA: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MIDDLE EAST: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 89
GCC COUNTRIES: CELL CULTURE MARKET FOR CHEMICALLY-DEFINED MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 90
SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 91
CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 93
EUROPE: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 94
ASIA PACIFIC: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 95
LATIN AMERICA: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 96
MIDDLE EAST: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 97
GCC COUNTRIES: CELL CULTURE MARKET FOR SPECIALTY MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 98
OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 99
CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 101
EUROPE: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 102
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 103
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 104
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER MEDIA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 105
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER MEDIA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 106
CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 107
CELL CULTURE REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 108
NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 109
EUROPE: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 110
ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 111
LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 112
MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 113
GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 114
CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 115
NORTH AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 116
EUROPE: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 117
ASIA PACIFIC: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 118
LATIN AMERICA: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 119
MIDDLE EAST: CELL CULTURE MARKET FOR GROWTH FACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 120
GCC COUNTRIES: CELL CULTURE MARKET FOR GROWTH FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 121
CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 122
NORTH AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 123
EUROPE: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 124
ASIA PACIFIC: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 125
LATIN AMERICA: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 126
MIDDLE EAST: CELL CULTURE MARKET FOR SUPPLEMENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 127
GCC COUNTRIES: CELL CULTURE MARKET FOR SUPPLEMENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 128
CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 129
NORTH AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 130
EUROPE: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 131
ASIA PACIFIC: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 132
LATIN AMERICA: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 133
MIDDLE EAST: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 134
GCC COUNTRIES: CELL CULTURE MARKET FOR BUFFERS & CHEMICALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 135
CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 136
NORTH AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 137
EUROPE: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 138
ASIA PACIFIC: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 139
LATIN AMERICA: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 140
MIDDLE EAST: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 141
GCC COUNTRIES: CELL CULTURE MARKET FOR CELL DISSOCIATION REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 142
CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 143
NORTH AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 144
EUROPE: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 145
ASIA PACIFIC: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 146
LATIN AMERICA: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 147
MIDDLE EAST: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 148
GCC COUNTRIES: CELL CULTURE MARKET FOR BALANCED SALT SOLUTIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 149
CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 150
NORTH AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 151
EUROPE: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 152
ASIA PACIFIC: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 153
LATIN AMERICA: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 154
MIDDLE EAST: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 155
GCC COUNTRIES: CELL CULTURE MARKET FOR ATTACHMENT & MATRIX FACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 156
CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 157
NORTH AMERICA: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 158
EUROPE: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 159
ASIA PACIFIC: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 160
LATIN AMERICA: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 161
MIDDLE EAST: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 162
GCC COUNTRIES: CELL CULTURE MEDIA FOR ANTIBIOTICS/ANTIMYCOTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 163
CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 164
NORTH AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 165
EUROPE: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 166
ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 167
LATIN AMERICA: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 168
MIDDLE EAST: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 169
GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOPROTECTIVE REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 170
CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 171
NORTH AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 172
EUROPE: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 173
ASIA PACIFIC: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 174
LATIN AMERICA: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 175
MIDDLE EAST: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 176
GCC COUNTRIES: CELL CULTURE MARKET FOR CONTAMINATION DETECTION KITS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 177
CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 178
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 179
EUROPE: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 180
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 181
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 182
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER REAGENTS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 183
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 184
CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 185
CELL CULTURE SERA MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 186
NORTH AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 187
EUROPE: CELL CULTURE SERA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ASIA PACIFIC: CELL CULTURE SERA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 189
LATIN AMERICA: CELL CULTURE SERA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 190
MIDDLE EAST: CELL CULTURE SERA MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 191
GCC COUNTRIES: CELL CULTURE SERA MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 192
CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 193
NORTH AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 194
EUROPE: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 195
ASIA PACIFIC: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 196
LATIN AMERICA: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 197
MIDDLE EAST: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 198
GCC COUNTRIES: CELL CULTURE MEDIA FOR FETAL BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 199
CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 200
NORTH AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 201
EUROPE: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 202
ASIA PACIFIC: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 203
LATIN AMERICA: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 204
MIDDLE EAST: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 205
GCC COUNTRIES: CELL CULTURE MEDIA FOR ADULT BOVINE SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 206
CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 207
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 208
EUROPE: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 209
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 210
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 211
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 212
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER ANIMAL SERA, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 213
CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 214
CELL CULTURE VESSELS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 215
NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 216
EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 217
ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 218
LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 219
MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 220
GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 221
CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 222
NORTH AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 223
EUROPE: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 224
ASIA PACIFIC: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 225
LATIN AMERICA: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 226
MIDDLE EAST: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 227
GCC COUNTRIES: CELL CULTURE MARKET FOR CELL FACTORY SYSTEMS/ CELL STACKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 228
CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 229
NORTH AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 230
EUROPE: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 231
ASIA PACIFIC: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 232
LATIN AMERICA: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 233
MIDDLE EAST: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 234
GCC COUNTRIES: CELL CULTURE MARKET FOR ROLLER/ROUX BOTTLES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 235
CELL CULTURE MARKET FOR FLASKS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 236
NORTH AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 237
EUROPE: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 238
ASIA PACIFIC: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 239
LATIN AMERICA: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 240
MIDDLE EAST: CELL CULTURE MARKET FOR FLASKS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 241
GCC COUNTRIES: CELL CULTURE MARKET FOR FLASKS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 242
CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 243
NORTH AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 244
EUROPE: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 245
ASIA PACIFIC: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 246
LATIN AMERICA: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 247
MIDDLE EAST: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 248
GCC COUNTRIES: CELL CULTURE MARKET FOR MULTIWELL PLATES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 249
CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 250
NORTH AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 251
EUROPE: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 252
ASIA PACIFIC: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 253
LATIN AMERICA: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 254
MIDDLE EAST: CELL CULTURE MARKET FOR PETRI DISHES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 255
GCC COUNTRIES: CELL CULTURE MARKET FOR PETRI DISHES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 256
CELL CULTURE ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 257
NORTH AMERICA: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 258
EUROPE: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 259
ASIA PACIFIC: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 260
LATIN AMERICA: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 261
MIDDLE EAST: CELL CULTURE ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 262
GCC COUNTRIES: CELL CULTURE ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 263
CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 264
CELL CULTURE EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 265
NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 266
EUROPE: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 267
ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 268
LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 269
MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 270
GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 271
CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 272
CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 273
NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 274
EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 275
ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 276
LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 277
MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 278
GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 279
CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 280
NORTH AMERICA: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 281
EUROPE: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 282
ASIA PACIFIC: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 283
LATIN AMERICA: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 284
MIDDLE EAST: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 285
GCC COUNTRIES: CELL CULTURE MARKET FOR CONVENTIONAL BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 286
COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS BY KEY PLAYERS
 
 
 
 
 
 
TABLE 287
CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 288
NORTH AMERICA: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 289
EUROPE: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 290
ASIA PACIFIC: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 291
LATIN AMERICA: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 292
MIDDLE EAST: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 293
GCC COUNTRIES: CELL CULTURE MARKET FOR SINGLE-USE BIOREACTORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 294
CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 295
CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 296
NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 297
EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 298
ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 299
LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 300
MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 301
GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 302
CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 303
NORTH AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 304
EUROPE: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 305
ASIA PACIFIC: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 306
LATIN AMERICA: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 307
MIDDLE EAST: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 308
GCC COUNTRIES: CELL CULTURE MARKET FOR REFRIGERATORS & FREEZERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 309
CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 310
NORTH AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 311
EUROPE: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 312
ASIA PACIFIC: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 313
LATIN AMERICA: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 314
MIDDLE EAST: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 315
GCC COUNTRIES: CELL CULTURE MARKET FOR CRYOSTORAGE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 316
CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 317
CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 318
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 319
EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 320
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 321
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 322
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 323
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 324
FILTRATION SYSTEMS OFFERED BY KEY PLAYERS
 
 
 
 
 
 
TABLE 325
CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 326
NORTH AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 327
EUROPE: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 328
ASIA PACIFIC: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 329
LATIN AMERICA: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 330
MIDDLE EAST: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 331
GCC COUNTRIES: CELL CULTURE MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 332
CELL COUNTERS OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 333
CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 334
NORTH AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 335
EUROPE: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 336
ASIA PACIFIC: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 337
LATIN AMERICA: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 338
MIDDLE EAST: CELL CULTURE MARKET FOR CELL COUNTERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 339
GCC COUNTRIES: CELL CULTURE MARKET FOR CELL COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 340
CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 341
CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 342
NORTH AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 343
EUROPE: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 344
ASIA PACIFIC: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 345
LATIN AMERICA: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 346
MIDDLE EAST: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 347
GCC COUNTRIES: CELL CULTURE MARKET FOR CARBON DIOXIDE INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 348
CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 349
CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 350
NORTH AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 351
EUROPE: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 352
ASIA PACIFIC: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 353
LATIN AMERICA: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 354
MIDDLE EAST: CELL CULTURE MARKET FOR CENTRIFUGES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 355
GCC COUNTRIES: CELL CULTURE MARKET FOR CENTRIFUGES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 356
CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 357
NORTH AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 358
EUROPE: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 359
ASIA PACIFIC: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 360
LATIN AMERICA: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 361
MIDDLE EAST: CELL CULTURE MARKET FOR AUTOCLAVES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 362
GCC COUNTRIES: CELL CULTURE MARKET FOR AUTOCLAVES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 363
CELL CULTURE MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 364
NORTH AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 365
EUROPE: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 366
ASIA PACIFIC: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 367
LATIN AMERICA: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 368
MIDDLE EAST: CELL CULTURE MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 369
GCC COUNTRIES: CELL CULTURE MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 370
BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 371
CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 372
NORTH AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 373
EUROPE: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 374
ASIA PACIFIC: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 375
LATIN AMERICA: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 376
MIDDLE EAST: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 377
GCC COUNTRIES: CELL CULTURE MARKET FOR BIOSAFETY CABINETS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 378
OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS
 
 
 
 
 
 
TABLE 379
CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 380
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 381
EUROPE: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 382
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 383
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 384
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 385
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER SUPPORTING EQUIPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 386
CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 387
CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 388
CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 389
NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 390
EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 391
ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 392
LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 393
MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 394
GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 395
CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 396
NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 397
EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 398
ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 399
LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 400
MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 401
GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 402
CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 403
NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 404
EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 405
ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 406
LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 407
MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 408
GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 409
CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 410
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 411
EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 412
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 413
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 414
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 415
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 416
CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 417
NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 418
EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 419
ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 420
LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTI CS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 421
MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 422
GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 423
CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 424
NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 425
EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 426
ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 427
LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 428
MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 429
GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 430
CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 431
CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 432
NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 433
EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 434
ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 435
LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 436
MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 437
GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 438
CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 439
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 440
EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 441
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 442
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 443
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 444
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 445
CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 446
NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 447
EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 448
ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 449
LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 450
MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 451
GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 452
CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 453
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 454
EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 455
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 456
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 457
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 458
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 459
CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 460
RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR, 2021–2024
 
 
 
 
 
 
TABLE 461
CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 462
NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 463
EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 464
ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 465
LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 466
MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 467
GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 468
CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 469
NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 470
EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 471
ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 472
LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 473
MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 474
GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 475
CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 476
NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 477
EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 478
ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 479
LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 480
MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 481
GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 482
CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 483
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 484
EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 485
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 486
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 487
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 488
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 489
CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 490
NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 491
NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 492
NORTH AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 493
NORTH AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 494
NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 495
NORTH AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 496
NORTH AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 497
NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 498
NORTH AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 499
NORTH AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 500
NORTH AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 501
NORTH AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 502
NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 503
NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 504
NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 505
NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 506
INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2024-2024
 
 
 
 
 
 
TABLE 507
US: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 508
US: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 509
US: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 510
US: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 511
US: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 512
US: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 513
US: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 514
US: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 515
US: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 516
US: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 517
US: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 518
US: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 519
US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 520
US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 521
US: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 522
CANADA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 523
CANADA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 524
CANADA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 525
CANADA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 526
CANADA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 527
CANADA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 528
CANADA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 529
CANADA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 530
CANADA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 531
CANADA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 532
CANADA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 533
CANADA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 534
CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 535
CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 536
CANADA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 537
EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 538
EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 539
EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 540
EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 541
EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 542
EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 543
EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 544
EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 545
EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 546
EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 547
EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 548
EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 549
EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 550
EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 551
EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 552
EUROPE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 553
GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 554
GERMANY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 555
GERMANY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 556
GERMANY: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 557
GERMANY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 558
GERMANY: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 559
GERMANY: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 560
GERMANY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 561
GERMANY: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 562
GERMANY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 563
GERMANY: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 564
GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 565
GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 566
GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 567
GERMANY: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 568
UK: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 569
UK: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 570
UK: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 571
UK: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 572
UK: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 573
UK: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 574
UK: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 575
UK: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 576
UK: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 577
UK: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 578
UK: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 579
UK: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 580
UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 581
UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 582
UK: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 583
FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 584
FRANCE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 585
FRANCE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 586
FRANCE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 587
FRANCE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 588
FRANCE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 589
FRANCE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 590
FRANCE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 591
FRANCE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 592
FRANCE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 593
FRANCE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 594
FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 595
FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 596
FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 597
FRANCE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 598
ITALY: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 599
ITALY: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 600
ITALY: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 601
ITALY: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 602
ITALY: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 603
ITALY: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 604
ITALY: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 605
ITALY: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 606
ITALY: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 607
ITALY: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 608
ITALY: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 609
ITALY: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 610
ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 611
ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 612
ITALY: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 613
SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 614
SPAIN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 615
SPAIN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 616
SPAIN: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 617
SPAIN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 618
SPAIN: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 619
SPAIN: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 620
SPAIN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 621
SPAIN: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 622
SPAIN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 623
SPAIN: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 624
SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 625
SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 626
SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 627
SPAIN: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 628
REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 629
REST OF EUROPE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 630
REST OF EUROPE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 631
REST OF EUROPE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 632
REST OF EUROPE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 633
REST OF EUROPE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 634
REST OF EUROPE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 635
REST OF EUROPE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 636
REST OF EUROPE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 637
REST OF EUROPE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 638
REST OF EUROPE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 639
REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 640
REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 641
REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 642
REST OF EUROPE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 643
ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 644
ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 645
ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 646
ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 647
ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 648
ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 649
ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 650
ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 651
ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 652
ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 653
ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 654
ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 655
ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 656
ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 657
ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 658
ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 659
CHINA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 660
CHINA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 661
CHINA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 662
CHINA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 663
CHINA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 664
CHINA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 665
CHINA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 666
CHINA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 667
CHINA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 668
CHINA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 669
CHINA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 670
CHINA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 671
CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 672
CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 673
CHINA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 674
JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 675
JAPAN: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 676
JAPAN: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 677
JAPAN: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 678
JAPAN: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 679
JAPAN: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 680
JAPAN: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 681
JAPAN: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 682
JAPAN: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 683
JAPAN: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 684
JAPAN: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 685
JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 686
JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 687
JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 688
JAPAN: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 689
INDIA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 690
INDIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 691
INDIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 692
INDIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 693
INDIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 694
INDIA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 695
INDIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 696
INDIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 697
INDIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 698
INDIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 699
INDIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 700
INDIA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 701
INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 702
INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 703
INDIA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 704
SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 705
SOUTH KOREA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 706
SOUTH KOREA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 707
SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 708
SOUTH KOREA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 709
SOUTH KOREA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 710
SOUTH KOREA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 711
SOUTH KOREA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 712
SOUTH KOREA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 713
SOUTH KOREA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 714
SOUTH KOREA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 715
SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 716
SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 717
SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 718
SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 719
AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 720
AUSTRALIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 721
AUSTRALIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 722
AUSTRALIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 723
AUSTRALIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 724
AUSTRALIA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 725
AUSTRALIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 726
AUSTRALIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 727
AUSTRALIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 728
AUSTRALIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 729
AUSTRALIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 730
AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 731
AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 732
AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 733
AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 734
REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 735
REST OF ASIA PACIFIC: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 736
REST OF ASIA PACIFIC: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 737
REST OF ASIA PACIFIC: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 738
REST OF ASIA PACIFIC: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 739
REST OF ASIA PACIFIC: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 740
REST OF ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 741
REST OF ASIA PACIFIC: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 742
REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 743
REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 744
REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 745
REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 746
REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 747
REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 748
REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 749
LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 750
LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 751
LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 752
LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 753
LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 754
LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 755
LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 756
LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 757
LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 758
LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 759
LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 760
LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 761
LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 762
LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 763
LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 764
LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 765
BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 766
BRAZIL: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 767
BRAZIL: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 768
BRAZIL: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 769
BRAZIL: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 770
BRAZIL: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 771
BRAZIL: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 772
BRAZIL: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 773
BRAZIL: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 774
BRAZIL: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 775
BRAZIL: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 776
BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 777
BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 778
BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 779
BRAZIL: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 780
MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 781
MEXICO: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 782
MEXICO: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 783
MEXICO: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 784
MEXICO: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 785
MEXICO: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 786
MEXICO: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 787
MEXICO: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 788
MEXICO: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 789
MEXICO: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 790
MEXICO: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 791
MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 792
MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 793
MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 794
MEXICO: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 795
REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 796
REST OF LATIN AMERICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 797
REST OF LATIN AMERICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 798
REST OF LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 799
REST OF LATIN AMERICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 800
REST OF LATIN AMERICA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 801
REST OF LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 802
REST OF LATIN AMERICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 803
REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 804
REST OF LATIN AMERICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 805
REST OF LATIN AMERICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 806
REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 807
REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 808
REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 809
REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 810
MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 811
MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 812
MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 813
MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 814
MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 815
MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 816
MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 817
MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 818
MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 819
MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 820
MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 821
MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 822
MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 823
MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 824
MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 825
MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 826
GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 827
GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 828
GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 829
GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 830
GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 831
GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 832
GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 833
GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 834
GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 835
GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 836
GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 837
GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 838
GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 839
GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 840
GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 841
GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 842
SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 843
SAUDI ARABIA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 844
SAUDI ARABIA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 845
SAUDI ARABIA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 846
SAUDI ARABIA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 847
SAUDI ARABIA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 848
SAUDI ARABIA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 849
SAUDI ARABIA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 850
SAUDI ARABIA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 851
SAUDI ARABIA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 852
SAUDI ARABIA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 853
SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 854
SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 855
SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 856
SAUDI ARABIA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 857
UAE: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 858
UAE: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 859
UAE: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 860
UAE: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 861
UAE: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 862
UAE: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 863
UAE: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 864
UAE: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 865
UAE: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 866
UAE: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 867
UAE: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 868
UAE: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 869
UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 870
UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 871
UAE: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 872
REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 873
REST OF GCC COUNTRIES: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 874
REST OF GCC COUNTRIES: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 875
REST OF GCC COUNTRIES: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 876
REST OF GCC COUNTRIES: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 877
REST OF GCC COUNTRIES: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 878
REST OF GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 879
REST OF GCC COUNTRIES: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 880
REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 881
REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 882
REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 883
REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 884
REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 885
REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 886
REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 887
REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 888
REST OF MIDDLE EAST: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 889
REST OF MIDDLE EAST: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 890
REST OF MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 891
REST OF MIDDLE EAST: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 892
REST OF MIDDLE EAST: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 893
REST OF MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 894
REST OF MIDDLE EAST: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 895
REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOREACTORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 896
REST OF MIDDLE EAST: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 897
REST OF MIDDLE EAST: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 898
REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 899
REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 900
REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 901
REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 902
AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 903
AFRICA: CELL CULTURE CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 904
AFRICA: CELL CULTURE SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 905
AFRICA: CELL CULTURE MEDIA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 906
AFRICA: CELL CULTURE REAGENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 907
AFRICA: CELL CULTURE SERA MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 908
AFRICA: CELL CULTURE VESSELS MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 909
AFRICA: CELL CULTURE EQUIPMENT MARKET, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 910
AFRICA: CELL CULTURE MARKET FOR BIOREACTORS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 911
AFRICA: CELL CULTURE MARKET FOR STORAGE EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 912
AFRICA: CELL CULTURE MARKET FOR OTHER EQUIPMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 913
AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 914
AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 915
AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 916
AFRICA: CELL CULTURE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
 
 
TABLE 917
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, JANUARY 2022−JUNE 2025
 
 
 
 
 
 
TABLE 918
CELL CULTURE MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 919
CELL CULTURE MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 920
CELL CULTURE MARKET: PRODUCT FOOTPRINT
 
 
 
 
 
 
TABLE 921
CELL CULTURE MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 922
CELL CULTURE MARKET: END-USER FOOTPRINT
 
 
 
 
 
 
TABLE 923
CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 924
CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 925
CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 926
CELL CULTURE MARKET: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 927
CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 928
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 929
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 930
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 931
THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 932
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 933
DANAHER: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 934
DANAHER: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 935
DANAHER: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 936
DANAHER: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 937
DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 938
DANAHER: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 939
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 940
MERCK KGAA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 941
MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 942
MERCK KGAA: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 943
MERCK KGAA: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 944
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 945
SARTORIUS AG: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 946
SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 947
SARTORIUS AG.: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 948
SARTORIUS AG: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 949
CORNING INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 950
CORNING INCORPORATED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 951
CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 952
CORNING INCORPORATED: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 953
FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 954
FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 955
FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 956
FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 957
FUJIFILM HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 958
FUJIFILM HOLDINGS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 959
BD: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 960
BD: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 961
BD: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 962
BD: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 963
EPPENDORF SE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 964
EPPENDORF SE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 965
EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 966
EPPENDORF SE: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 967
EPPENDORF SE: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 968
LONZA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 969
LONZA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 970
LONZA: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 971
LONZA: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 972
GETINGE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 973
GETINGE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 974
GETINGE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 975
GETINGE: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 976
GETINGE: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 977
AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 978
AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 979
AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 980
AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 981
AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 982
HIMEDIA LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 983
HIMEDIA LABORATORIES: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 984
BIO-TECHNE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 985
BIO-TECHNE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 986
BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 987
BIO-TECHNE: DEALS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 988
BIO-TECHNE: EXPANSIONS, JANUARY 2021–JUNE 2025
 
 
 
 
 
 
TABLE 989
MILTENYI BIOTEC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 990
STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 991
SOLIDA BIOTECH GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 992
CAISSON LABS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 993
PROMOCELL GMBH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 994
INVIVOGEN: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 995
PAN-BIOTECH: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 996
CELLEXUS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 997
MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 998
ADOLF KÜHNER AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 999
ADVANCION CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 1000
BIOSPHERIX LLC: COMPANY OVERVIEW
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
CELL CULTURE MARKET SEGMENTATION
 
 
 
 
 
 
FIGURE 2
REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 3
CELL CULTURE MARKET: RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 4
CELL CULTURE MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
 
FIGURE 5
CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
 
 
 
 
 
 
FIGURE 6
MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2024
 
 
 
 
 
 
FIGURE 7
ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2024
 
 
 
 
 
 
FIGURE 8
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 9
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 10
CELL CULTURE MARKET: CAGR PROJECTIONS (2025-2030)
 
 
 
 
 
 
FIGURE 11
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 
FIGURE 12
CELL CULTURE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 13
CELL CULTURE MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 14
CELL CULTURE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
 
 
FIGURE 15
GEOGRAPHICAL SNAPSHOT OF CELL CULTURE MARKET
 
 
 
 
 
 
FIGURE 16
GROWING POPULARITY OF MONOCLONAL ANTIBODIES AND BIOSIMILARS TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 17
CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2024
 
 
 
 
 
 
FIGURE 18
BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
 
 
 
 
 
 
FIGURE 19
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED END-USER MARKET IN 2024
 
 
 
 
 
 
FIGURE 20
ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 21
CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 22
NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU, 2012−2024
 
 
 
 
 
 
FIGURE 23
NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED, 2015−2024
 
 
 
 
 
 
FIGURE 24
CLINICAL TRIAL OVERVIEW OF TISSUE-ENGINEERED PRODUCTS, 2019–2023
 
 
 
 
 
 
FIGURE 25
GLOBAL HIV EPIDEMIC, 2023
 
 
 
 
 
 
FIGURE 26
NEW REVENUE POCKETS FOR PLAYERS IN CELL CULTURE MARKET
 
 
 
 
 
 
FIGURE 27
AVERAGE SELLING PRICE TREND OF CELL-BASED ASSAY PRODUCTS, 2022–2024
 
 
 
 
 
 
FIGURE 28
CELL CULTURE MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 29
CELL CULTURE MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 30
CELL CULTURE MARKET: INVESTMENT AND FUNDING SCENARIO, 2020–2024
 
 
 
 
 
 
FIGURE 31
CELL CULTURE MARKET: PATENT ANALYSIS, 2014–2024
 
 
 
 
 
 
FIGURE 32
CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS
 
 
 
 
 
 
FIGURE 34
KEY BUYING CRITERIA, BY END USER
 
 
 
 
 
 
FIGURE 35
AI USE CASES
 
 
 
 
 
 
FIGURE 36
NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 37
ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 38
REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2020–2024 (USD BILLION)
 
 
 
 
 
 
FIGURE 39
MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2024
 
 
 
 
 
 
FIGURE 40
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 41
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 42
CELL CULTURE MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 43
CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
 
 
FIGURE 44
CELL CULTURE MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 45
CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
 
 
FIGURE 46
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 47
DANAHER: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 48
MERCK KGAA: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 49
SARTORIUS AG: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 50
CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 51
FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 52
BD: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 53
EPPENDORF SE: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 54
LONZA: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 55
GETINGE: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 56
AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 
FIGURE 57
BIO-TECHNE: COMPANY SNAPSHOT (2024)
 
 
 
 
 
 

Methodology

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell culture market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell culture market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration, American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT), American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), International Serum Industry Association (ISIA), Pharmaceutical Research and Manufacturers of America (PhRMA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), American Type Culture Collection (ATCC), and the Alliance for Regenerative Medicine (ARM); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

After acquiring foundational knowledge about the global cell culture market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical and biopharmaceutical companies, hospitals & diagnostic laboratories, research & academic institutes, and CROs. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

These interviews spanned five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

The following is a breakdown of the primary respondents:

Cell Culture Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell culture market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach and Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Cell Culture Market

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell culture refers to removing cells from an animal or plant and their subsequent growth in an artificial environment under controlled conditions. It is a process of growing cells outside their natural environment, typically in a laboratory setting. This technique allows researchers to study cells in a controlled environment, providing insights into their behavior, growth, metabolism, and response to various stimuli.

Stakeholders

  • Cell Culture Equipment and Reagents Manufacturers
  • Analytical and Life Science Instrumentation Companies
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Hospitals and Diagnostic Laboratories
  • Cell Banks

Report Objectives

  • To define, describe, and forecast the global cell culture market based on the product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall cell culture market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the cell culture market
  • To benchmark players within the cell culture market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

Key Questions Addressed by the Report

How is the preference for sustainable and animal-free components shaping the cell culture market?

There’s a growing shift toward serum-free, chemically defined media and single use technologies, driven by regulatory pressure, reproducibility issues, risk of contamination and ethical sourcing concerns. Adoption is particularly strong in Europe, where more than 40% of manufacturers reports transitioning to animal-free alternatives.

How is continuous manufacturing transforming the cell culture industry?

Continuous biomanufacturing is enabling real-time process monitoring, higher yields, and smaller facility footprints. In upstream cell culture, continuous perfusion systems are gaining traction and can improve productivity by 2–3x compared to traditional fed-batch processes.

How are automation and digitalization transforming cell culture workflows?

Integration of automated culture systems and AI-driven cell monitoring solutions used for media optimization, real-time cell monitoring, and predictive analytics is improving reproducibility and reducing manual error, with up to 30-40% efficiency gains in high-throughput labs.

How is the market being reshaped by the rise in advanced therapies (ATMPs)?

Cell and gene therapies are transforming the cell culture market landscape, with over 4,400 gene, cell and RNA-based therapies in development globally. This has pushed demand for GMP-grade media, automated systems, and closed bioprocessing platforms.

How is the shift towards 3D cell culture systems impacting R&D and preclinical testing?

3D cultures and organoids are gaining traction, especially in oncology, neurology, and toxicity testing reducing drug attrition rates and offering more physiologically relevant data than 2D cultures.

What are the primary supply chain concerns impacting the market today?

The industry is facing price volatility and procurement delays, especially for high-grade FBS, recombinant proteins, and lab plastics, urging firms to diversify suppliers and invest in supply chain resilience. Companies are responding by diversifying suppliers, expanding regional manufacturing, investing in in-house production, and using AI-based forecasting to improve resilience and reduce dependency on global supply chains.

What are the key pain points for companies scaling up from R&D to GMP manufacturing?

Key challenges include scaling adherent cells, ensuring batch-to-batch consistency, and adapting to closed, automated systems—especially for companies moving from research-grade reagents to clinical-grade platforms. To address this, they’re adopting closed, automated bioreactor systems, using pre-validated GMP media, and partnering with CDMOs for tech transfer and regulatory support.

Which government programs are actively investing in local cell culture manufacturing capacity?

Governments in China, Singapore, and India have launched biotech funds and incentives—e.g., China’s 14th Five-Year Plan, which includes $10B+ allocated to biomanufacturing infrastructure, boosting local cell culture production. Similarly, initiatives like India’s Biotechnology Industry Research Assistance Council (BIRAC) are accelerating biotech capacity, directly boosting media and reagent demand.

How will the 2025 US tariffs on Chinese biotech goods impact the cell culture supply chain?

Starting 2025, the US plans to impose 25% tariffs on certain Chinese-origin biologics and biomanufacturing equipment, including lab-grade media, reagents, plastics, and filtration units likely leading to 5–15% cost inflation for US-based manufacturers relying on Chinese imports. Firms are diversifying suppliers, localizing production of media and consumables, and entering strategic partnerships with domestic and EU-based vendors to secure critical raw materials and maintain compliance.

Are any regional disparities emerging in access to high-quality cell culture inputs?

Yes. Africa, LATAM, and parts of Southeast Asia face challenges accessing high-quality media and reagents due to import dependency, limited local suppliers, and regulatory bottlenecks highlighting a need for regional manufacturing hubs. To overcome this, companies and governments are investing in local production facilities, forming regional supply partnerships to improve access and self-sufficiency.

How are companies differentiating through product innovation in 2024–2025?

Companies are launching custom media formulations, 3D culture platforms, and closed single-use bioreactor systems. Recent launches such as Thermo Fisher’s Gibco CTS media line, Nucleus Biologics’s NB-KUL DF, a DMSO-free, chemically defined cryomedia target consistent performance in cell therapy and protein expression, respectively.

What recent strategic moves are shaping competition in the cell culture industry?

In the past 2 years, leading players have made multiple acquisitions (e.g., Sartorius acquiring Albumedix, Thermo Fisher acquiring PeproTech) and expanded GMP-grade media facilities to strengthen biologics and cell therapy manufacturing offerings. In 2024, Fujifilm invested $1.2 billion in its large-scale cell culture CDMO facility in North Carolina

 

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cell Culture Market

Alan

Mar, 2022

Which market size estimation methodologies are adopted to study the Global Cell Culture Market?.

Juan

Mar, 2022

How much percent share, does each segment holds, of the Global Cell Culture Market?.

Wayne

Mar, 2022

What are the growth opportunities in the Global Cell Culture Market across different geographies?.

DMCA.com Protection Status